CWM
ZNTL icon

Cornerstone Wealth Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Cornerstone Wealth Management’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.4K Hold
10,186
– – ﹤0.01% 737
2026
Q1 		$23.8K Buy
+10,186
New +$26.3K ﹤0.01% 710
2022
Q2 		– Sell
-6,607
Closed -$305K – 491
2022
Q1 		$305K Hold
6,607
– – 0.03% 360
2021
Q4 		$555K Sell
6,607
-2,000
-23% -$155K 0.05% 267
2021
Q3 		$574K Sell
8,607
-7,000
-45% -$404K 0.06% 246
2021
Q2 		$830K Hold
15,607
– – 0.09% 207
2021
Q1 		$677K Hold
15,607
– – 0.08% 225
2020
Q4 		$811K Buy
+15,607
New +$704K 0.1% 180

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Cornerstone Wealth Management's ZNTL Position: Q2 2026 in Review

Cornerstone Wealth Management held its Zentalis Pharmaceuticals (ZNTL) position steady in Q2 2026 at 10,186 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Cornerstone Wealth Management first reported a position in ZNTL in Q4 2020 and has held it in 8 quarters since. The position peaked at $830K in Q2 2021. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Cornerstone Wealth Management held 10,186 shares of Zentalis Pharmaceuticals worth $49.4K as of Q2 2026.
  • Cornerstone Wealth Management left its Zentalis Pharmaceuticals share count unchanged in Q2 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Cornerstone Wealth Management's portfolio in Q2 2026, its #737 holding.
  • Cornerstone Wealth Management first reported a position in Zentalis Pharmaceuticals in Q4 2020 and has held it in 8 quarters since.
  • Cornerstone Wealth Management's Zentalis Pharmaceuticals position peaked at $830K in Q2 2021.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.